Frank Schneider1, Michael Erhart, Walter Hewer, Leonie Ak Loeffler, Frank Jacobi. 1. University Hospital Düsseldorf; Central Institute for Ambulatory Care in Germany, Berlin, Germany; Alice Salomon University Berlin, Germany; Department of Geriatric Psychiatry, Christophsbad Hospital, Göppingen, Germany; Department of Psychiatry, Psychotherapy and Psychosomatics, School of Medicine, RWTH Aachen University, Aachen, Germany; Psychologische Hochschule Berlin, Berlin, Germany.
Abstract
BACKGROUND: Mentally ill patients die on average 10 years earlier than the general population, largely due to general medical disorders. This study is the first to explore in a large German sample the prevalence, mortality, and medical comorbidity in pa- tients with severe mental illness (SMI). The patients were affected by borderline personality disorder (BPD), psychotic disorders, bipolar disorder, or severe unipolar depression. METHODS: Our database consists of billing data from all adults with statutory health insurance in Germany. Twelve-month administrative SMI prevalence and medical comorbidity were estimated using cross-sectional data from 2016 (age ≥ 18; N = 59 561 310). Two-year mortality was established longitudinally in a randomly selected subset of the billing data (most recent mortality information available for 2012 to 2014; 2012: n = 15 590 107). RESULTS: Severe unipolar depression had the highest prevalence (2.01%), followed by psychotic disorders (1.25%), BPD (0.34%), and bipolar disorder (0.29%). While the prevalence of malignant neoplasms showed moderate deviations from reference values [severe unipolar depression: OR = 1.30 (95% CI = 1.29; 1.31), BPD: OR = 1.11 (1.09; 1.14), psychotic dis- orders: OR = 0.90 (0.89; 0.90), bipolar disorder: OR = 1.07 (1.06; 1.09)], other disease groups (infectious, endocrine/nutritional/ metabolic, circulatory, respiratory) were substantially elevated in all categories of SMI. Mortality rates for psychotic disorders, BPD, bipolar disorder, and severe unipolar depression were increased (OR = 2.38 [95% CI=2.32; 2.44], 2.30 [2.08; 2.54], 1.52 [1.42; 1.62], and 1.40 [1.37; 1.44], respectively), with a loss of 2.6 to 12.3 years, depending on age, sex, and SMI. CONCLUSION: Mortality is substantially elevated in all SMI patients. The results underline the need to remove barriers to adequate general medical care, both on the patient and the provider side, to reduce excess mortality.
BACKGROUND:Mentally illpatients die on average 10 years earlier than the general population, largely due to general medical disorders. This study is the first to explore in a large German sample the prevalence, mortality, and medical comorbidity in pa- tients with severe mental illness (SMI). The patients were affected by borderline personality disorder (BPD), psychotic disorders, bipolar disorder, or severe unipolar depression. METHODS: Our database consists of billing data from all adults with statutory health insurance in Germany. Twelve-month administrative SMI prevalence and medical comorbidity were estimated using cross-sectional data from 2016 (age ≥ 18; N = 59 561 310). Two-year mortality was established longitudinally in a randomly selected subset of the billing data (most recent mortality information available for 2012 to 2014; 2012: n = 15 590 107). RESULTS: Severe unipolar depression had the highest prevalence (2.01%), followed by psychotic disorders (1.25%), BPD (0.34%), and bipolar disorder (0.29%). While the prevalence of malignant neoplasms showed moderate deviations from reference values [severe unipolar depression: OR = 1.30 (95% CI = 1.29; 1.31), BPD: OR = 1.11 (1.09; 1.14), psychotic dis- orders: OR = 0.90 (0.89; 0.90), bipolar disorder: OR = 1.07 (1.06; 1.09)], other disease groups (infectious, endocrine/nutritional/ metabolic, circulatory, respiratory) were substantially elevated in all categories of SMI. Mortality rates for psychotic disorders, BPD, bipolar disorder, and severe unipolar depression were increased (OR = 2.38 [95% CI=2.32; 2.44], 2.30 [2.08; 2.54], 1.52 [1.42; 1.62], and 1.40 [1.37; 1.44], respectively), with a loss of 2.6 to 12.3 years, depending on age, sex, and SMI. CONCLUSION: Mortality is substantially elevated in all SMI patients. The results underline the need to remove barriers to adequate general medical care, both on the patient and the provider side, to reduce excess mortality.
Authors: Benjamin G Druss; Liping Zhao; Silke A von Esenwein; Joseph R Bona; Larry Fricks; Sherry Jenkins-Tucker; Evelina Sterling; Ralph Diclemente; Kate Lorig Journal: Schizophr Res Date: 2010-02-25 Impact factor: 4.939
Authors: Jari Tiihonen; Jouko Lönnqvist; Kristian Wahlbeck; Timo Klaukka; Leo Niskanen; Antti Tanskanen; Jari Haukka Journal: Lancet Date: 2009-08-22 Impact factor: 79.321
Authors: Ronald C Kessler; Sergio Aguilar-Gaxiola; Jordi Alonso; Somnath Chatterji; Sing Lee; Johan Ormel; T Bedirhan Ustün; Philip S Wang Journal: Epidemiol Psichiatr Soc Date: 2009 Jan-Mar
Authors: M A Rapp; M Tschorn; T Supprian; C Thomas; S Kreisel; J Benninghoff; G Schumann; A Heinz Journal: Nervenarzt Date: 2020-11-26 Impact factor: 1.214
Authors: Sarah Kittel-Schneider; Daniel Bury; Karolina Leopold; Sara Haack; Michael Bauer; Steffi Pfeiffer; Cathrin Sauer; Andrea Pfennig; Henry Völzke; Hans-Jörgen Grabe; Andreas Reif Journal: Front Psychiatry Date: 2020-04-22 Impact factor: 4.157
Authors: Ole Jakob Storebø; Johanne Pereira Ribeiro; Mickey T Kongerslev; Jutta Stoffers-Winterling; Mie Sedoc Jørgensen; Klaus Lieb; Anthony Bateman; Richard Kirubakaran; Nicolas Dérian; Eirini Karyotaki; Pim Cuijpers; Erik Simonsen Journal: BMJ Open Date: 2021-06-21 Impact factor: 2.692